ITK | IL2-inducible T-cell kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70314/154735_A_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
KBTBD8 | Kelch repeat and BTB (POZ) domain containing 8 | Cytoskeleton related proteins Predicted intracellular proteins
| ![](/images/41285/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41285/89084_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
KIAA0125 | KIAA0125 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KIAA0226L | KIAA0226-like | Predicted intracellular proteins
| ![](/images/26614/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26614/61656_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
KLHL6 | Kelch-like family member 6 | Predicted intracellular proteins
| ![](/images/24512/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24512/52717_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
KLRG1 | Killer cell lectin-like receptor subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/51403/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51403/116375_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21896/49187_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
LAIR2 | Leukocyte-associated immunoglobulin-like receptor 2 | CD markers Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images/11157/if_selected_60x60.jpg) | | ![](/images/2223/5872_A_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/3494/if_selected_60x60.jpg) | | ![](/images/3816/10092_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | ![](/images/2087/if_selected_60x60.jpg) | | ![](/images/2087/7385_B_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
LILRA4 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 | CD markers Predicted membrane proteins
| ![](/images/49418/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49418/118152_B_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
LILRB4 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | CD markers Predicted intracellular proteins Predicted membrane proteins
| ![](/images/52807/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52807/121298_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
LIMD2 | LIM domain containing 2 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/62867/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | ![](/images/2967/9462_A_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
LTA | Lymphotoxin alpha | Cancer-related genes Disease related genes Predicted secreted proteins
| ![](/images/7729/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7729/28403_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44895/124860_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
LY9 | Lymphocyte antigen 9 | CD markers Predicted intracellular proteins Predicted membrane proteins
| ![](/images/50917/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50917/121036_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 | Cancer-related genes Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes Predicted intracellular proteins
| | ![](/images/7754/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7419/20101_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MDS2 | Myelodysplastic syndrome 2 translocation associated | Disease related genes Predicted intracellular proteins
| ![](/images/52999/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/52999/ihc_cell_selected_60x60.jpg) | ![](/images/52999/119847_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/1238/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/63909/152372_A_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MYBL1 | V-myb avian myeloblastosis viral oncogene homolog-like 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images/8791/ihc_selected_60x60.jpg) | ![](/images/8791/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/8791/146564_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/30530/92530_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47836/129864_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NCR3 | Natural cytotoxicity triggering receptor 3 | CD markers Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
NLRC3 | NLR family, CARD domain containing 3 | Plasma proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
NUGGC | Nuclear GTPase, germinal center associated | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
OCM | Oncomodulin | Predicted intracellular proteins
| ![](/images/46422/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46422/102737_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY10 | Purinergic receptor P2Y, G-protein coupled, 10 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/36757/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36757/74359_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY8 | Purinergic receptor P2Y, G-protein coupled, 8 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| ![](/images/3631/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3631/11260_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PARP15 | Poly (ADP-ribose) polymerase family, member 15 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PATL2 | Protein associated with topoisomerase II homolog 2 (yeast) | Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/56394/140589_A_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
PDCD1 | Programmed cell death 1 | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38418/74794_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
PDE6G | Phosphodiesterase 6G, cGMP-specific, rod, gamma | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PLA2G2D | Phospholipase A2, group IID | Enzymes Predicted secreted proteins RAS pathway related proteins
| ![](/images/46308/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46308/102936_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | ![](/images/20099/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4280/18879_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
PMCH | Pro-melanin-concentrating hormone | Predicted secreted proteins
| ![](/images/46055/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46055/108750_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
PNOC | Prepronociceptin | Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
POU2AF1 | POU class 2 associating factor 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| ![](/images/11193/27220_A_6_8_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/11193/ihc_cell_selected_60x60.jpg) | ![](/images/11193/27218_A_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PPIAL4C | Peptidylprolyl isomerase A (cyclophilin A)-like 4C | Predicted intracellular proteins
| ![](/images/58345/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58345/145680_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
PTCRA | Pre T-cell antigen receptor alpha | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PTPN7 | Protein tyrosine phosphatase, non-receptor type 7 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19118/45199_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43734/97692_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
PVRIG | Poliovirus receptor related immunoglobulin domain containing | Predicted membrane proteins
| | ![](/images/47497/1365_E3_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/47497/106258_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PYHIN1 | Pyrin and HIN domain family, member 1 | Predicted intracellular proteins
| ![](/images/51224/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51224/116046_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43417/119259_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
RASGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |